Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen...

Administration (FDA) approved a biologic license application (BLA) for alglucosidase alfa, rhGAA (Myozyme), the first treatment for patients with Pompe disease...

drug alglucosidase alfa became the first released treatment for Pompe disease and acts as an analog to α-glucosidase. Further studies of alglucosidase alfa...

Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe...

filler), for facial wrinkles. Lumizyme (Alglucosidase alfa), for Pompe disease. Myozyme (Alglucosidase alfa), for Pompe disease. Sculptra (Polylactic...

Imiglucerase A16AB03 Agalsidase alfa A16AB04 Agalsidase beta A16AB05 Laronidase A16AB06 Sacrosidase A16AB07 Alglucosidase alfa A16AB08 Galsulfase A16AB09 Idursulfase...

Sebelipase alfa IV MPS I Laronidase IV MPS II Idursulfase IV MPS IVA Elosulfase alfa IV MPS VI Galsulfase IV Pompe disease Alglucosidase alfa (160L bioreactor)...

approval of the first enzyme replacement therapy for Pompe's disease - Alglucosidase alfa (Myozyme or Lumizyme, Genzyme Inc) in 2006. William Canfield's work...

(December 2021). "Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an...

algeldrate (INN) algenpantucel-L (USAN) algestone (INN) alglucerase (INN) alglucosidase alfa (USAN) alibendol (INN) alicaforsen (INN, USAN) aliconazole (INN) alifedrine...

Foundation Website 2010 NEJM, 2010, 362:1396–1406 A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease Suberoylanilide hydroxamic acid (SAHA;...